1. Home
  2. Stocks
  3. Orchpharma Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Orchid Pharma Share Price Orchid Pharma

    Mid Cap
    ₹1,078.7
    -13.7 (-1.25%)
    26 April, 2024 10:37 BSE: 524372 NSE: ORCHPHARMAISIN: INE191A01027

    Start SIP in Orchid Pharma

    Start SIP

    Orchid Pharma Performance

    Day Range

    • Low 1,076
    • High 1,118
    ₹ 1,078

    52 Week Range

    • Low 380
    • High 1,360
    ₹ 1,078
    • Open Price1,102
    • Previous Close1,092
    • Volume15591

    Orchid Pharma Share Price

    • Over 1 Month +2.11%
    • Over 3 Month +51.3%
    • Over 6 Month +139.42%
    • Over 1 Year +172.4%

    Orchid Pharma Key Statistics

    P/E Ratio 46.5
    PEG Ratio 0.1
    Market Cap Cr 5,471
    Price to Book Ratio 7.9
    EPS 2.8
    Dividend 0
    Relative Strength Index 52.29
    Money Flow Index 46.61
    MACD Signal 9.01
    Average True Range 57.54
    Orchid Pharma Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 221199183210
    Operating Expenses Qtr Cr 185175161170
    Operating Profit Qtr Cr 36242240
    Depreciation Qtr Cr 9887
    Interest Qtr Cr 4467
    Tax Qtr Cr 0000
    Net Profit Qtr Cr 31201165
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 685
    Operating Expenses Annual Cr 582
    Operating Profit Annual in Cr 84
    Depreciation Cr 55
    Interest Annual Cr 32
    Tax Annual Cr 0
    Net Profit Annual Cr 54
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 13
    Cash from Investing Activity Annual Cr -27
    Cash from Financing Annual Activity Cr 31
    Net Cash Flow Annual Cr 18
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 732
    Fixed Assets Annual Cr 619
    Total Non Current Assets Annual Cr 729
    Total Current Assets Annual Cr 494
    Total Assets Annual Cr 1,223
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 179
    ROE Annual % 7
    ROCE Annual % 5
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 15
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 221199183210
    Operating Expenses Qtr Cr 185175161170
    Operating Profit Qtr Cr 35232240
    Depreciation Qtr Cr 9887
    Interest Qtr Cr 4467
    Tax Qtr Cr 0000
    Net Profit Qtr Cr 2920959
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 685
    Operating Expenses Annual Cr 582
    Operating Profit Annual in Cr 84
    Depreciation Cr 55
    Interest Annual Cr 32
    Tax Annual Cr 0
    Net Profit Annual Cr 46
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 18
    Cash from Investing Activity Annual Cr -31
    Cash from Financing Annual Activity Cr 31
    Net Cash Flow Annual Cr 18
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 689
    Fixed Assets Annual Cr 620
    Total Non Current Assets Annual Cr 724
    Total Current Assets Annual Cr 501
    Total Assets Annual Cr 1,225
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 169
    ROE Annual % 7
    ROCE Annual % 6
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 15
    Sign Up to Know More
    Invest in Orchid Pharma

    Orchid Pharma Technicals

    EMA & SMA

    Current Price
    ₹1,078.7
    -13.7 (-1.25%)
    pointer
    • Bullish Moving Average
    • ___
    • 9
    • Bearish Moving Average
    • ___
    • 7
    • 20 Day
    • ₹1,083.78
    • 50 Day
    • ₹1,042.12
    • 100 Day
    • ₹934.59
    • 200 Day
    • ₹784.42
    • 20 Day
    • ₹1,094.04
    • 50 Day
    • ₹1,098.87
    • 100 Day
    • ₹912.01
    • 200 Day
    • ₹723.30

    Orchid Pharma Resistance and Support

    PIVOT
    ₹1,087.47
    Resistance
    First Resistance 1,106.88
    Second Resistance 1,121.37
    Third Resistance 1,140.78
    RSI 52.29
    MFI 46.61
    MACD Single Line 9.01
    MACD 2.56
    Support
    First Resistance 1,072.98
    Second Resistance 1,053.57
    Third Resistance 1,039.08

    Orchid Pharma Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 55,898 3,422,076 61.22
    Week 62,955 3,863,561 61.37
    1 Month 184,531 13,348,973 72.34
    6 Month 294,438 15,366,735 52.19

    Orchid Pharma Result Highlights

    Orchid Pharma Synopsis

    NSE-Medical-Diversified

    Orchid Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 665.90 Cr. and Equity Capital is Rs. 40.82 Cr. for the Year ended 31/03/2023. Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994.
    Market Cap 5,529
    Sales 812
    Shares in Float 1.52
    No of funds 45
    Yield
    Book Value 6.08
    U/D Vol ratio 1.7
    LTDebt / Equity 20
    Alpha 0.52
    Beta 0.45

    Orchid Pharma

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 69.84%69.84%72.4%72.4%
    Mutual Funds 15.18%10.4%9.76%9.78%
    Insurance Companies 0.94%2.45%
    Foreign Portfolio Investors 1.96%4.14%8.08%8.58%
    Financial Institutions/ Banks 0.11%0.12%0.12%0.17%
    Individual Investors 7.44%7.79%3.85%3.1%
    Others 4.53%5.26%5.79%5.97%

    Orchid Pharma Management

    Name Designation
    Mr. Ram Gopal Agarwal Chairman & Non-Exe.Director
    Mr. Manish Dhanuka Managing Director
    Mr. Mridul Dhanuka Whole Time Director
    Mrs. Tanu Singla Independent Director
    Dr. Dharam Vir Independent Director
    Mr. Manoj Kumar Goyal Independent Director
    Mr. Mudit Tandon Independent Director

    Orchid Pharma Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Orchid Pharma Corporate Action

    Date Purpose Remarks
    2024-02-08 Quarterly Results
    2023-11-04 Quarterly Results
    2023-08-10 Quarterly Results
    2023-05-10 Audited Results
    2023-02-09 Quarterly Results

    Orchid Pharma MF Shareholding

    Name Amount(cr)
    Quant Small Cap Fund Growth 17,349
    Invesco India Contra Fund Growth 13,903
    Nippon India Pharma Fund - Growth 7,125
    Invesco India Smallcap Fund Regular Growth 3,670
    UTI Small Cap Fund Regular Growth 3,532

    Orchid Pharma FAQs

    What is Share Price of Orchid Pharma ?

    Orchid Pharma share price is ₹1,078 As on 26 April, 2024 | 10:23

    What is the Market Cap of Orchid Pharma ?

    The Market Cap of Orchid Pharma is ₹5471.1 Cr As on 26 April, 2024 | 10:23

    What is the P/E ratio of Orchid Pharma ?

    The P/E ratio of Orchid Pharma is 46.5 As on 26 April, 2024 | 10:23

    What is the PB ratio of Orchid Pharma ?

    The PB ratio of Orchid Pharma is 7.9 As on 26 April, 2024 | 10:23

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.